The Clinical Trial Center (CTC) strives to provide the clinical researcher with all the tools necessary to make your clinical study a straightforward, streamlined process. Clinical researchers at Loma Linda University Health (LLUH) are invited to take full advantage of resources available through our One Portal Intranet site. Access is only available while on campus and only with LLUH computer stations.
Use the Online Submission Form to submit a new study, a study amendment, or study closure.
Manage Your Clinical Study (Access via One Portal Intranet)
Processing a clinical study from onset to completion is a complex project. Careful planning is crucial in order to avoid any delays. Understanding the design and process of clinical studies can provide investigators and their staff with a comprehensive outline and detailed steps of the required processes in order to achieve the successful and efficient conduct of clinical studies. Information about processes for clinical studies and how they are designed is available on the Clinical Trials One Portal Intranet site. One Portal access is required.
Primary Investigators and Department Administrators can view the financial status of their Clinical Trials using the Clinical Trial Center Dashboard.
Support is available as needed to complete submissions to the IRB and to the FDA. Please contact the Clinical Trial Center should support be needed.
Guidelines announced for continuing research activities
We have been informed by the San Bernardino County Department of Public Health that research conducted at LLUH is an essential activity and therefore can continue under the following restrictions:
- Research activities that involve no in-person interaction with subjects may continue.
- For Ongoing Research with Enrolled Subjects: Research activities that involve in-person interaction with subjects must stop. The exceptions are:
- The research holds the potential for direct benefit to the subject (e.g., drug, device or surgical procedures) and the interaction is essential to deliver the potential benefit.
- Collection of safety data. Based solely on clinical judgment and the importance to discover potential safety issues and/or adverse events.
- Observational research where the interaction with the subject is needed for clinical care and the observational research is an incidental part of the interaction and does not increase the risk of exposure to Covid-19
- New Enrollment into Existing Studies: The majority of studies must stop enrolling new subjects. The exceptions are:
- The potential for direct benefit is greater than the increased risk of contracting Covid-19 AND similar benefits are not available through standard of care.
- Observational research where the interaction with the subject is needed for clinical care and the observational research is an incidental part of the interaction and does not increase the risk of exposure to Covid-19.
For further clarifications involving research on humans, please contact Amy Casey, Director, Human Research and Compliance (email@example.com).
Clinical Trial Center Services
The Clinical Trial Center is proud to offer a variety of services as highlighted below. We seek to partner with the Primary Investigator and research teams to support your clinical research activity. We will also serve as your primary contact during the study start up process. This leaves time for the principal investigator and study staff to plan for the start-up of the trial. Please reach out to the CTC if you have any questions.
Clinical Trial Center Study Process
This chart provides an at a glance look at the life cycle and processes involved with clinical research. CTC support is available every step of the way and serves as your primary contact with the study sponsor during your start-up process, which includes study budget and billing items. In addition, the CTC serves as the primary contact for budget amendment or payment concerns throughout the life of your study. Please feel free to contact the CTC with any questions or for assistance throughout the life cycle.